Sanofi and Regeneron Pharmaceutics, Inc, have convinced the FDA that their atopic dermatitis treatment works well enough to undergo accelerated development and regulatory review.
Many patients who claim to have penicillin allergies may not actually be allergic to the antibiotic.
Mylan Inc. today announced it has signed a multi-year strategic alliance agreement with Walt Disney Parks and Resorts to help increase awareness of anaphylaxis, a life-threatening allergic reaction. The agreement includes updated maps in Disney's domestic theme parks and on its cruise ships as well as updated signage in the parks that highlight locations with EpiPen® and EpiPen Jr® Auto-Injectors. Over time, the companies also will introduce a variety of educational resources designed to increase awareness of and preparedness for severe allergic reactions.